In this Viewpoint, John Ioannidis discusses implications of the 2017 hypertension guidelines for real-world management of blood pressure (BP), including labeling healthy people as having disease and possible adverse treatment effects at lower BP treatment targets..
Bryan Williams, Giuseppe Mancia, Wilko Spiering, Enrico G. Caiani, Michel Azizi, Michel Burnier, D Clément, António Coca, Giovanni de Simone, Anna F. Dominiczak, Thomas Kahan, Felix Mahfoud, Josep Redón, Luís M. Ruilope, Alberto Zanchetti, Mary Kerins, Sverre E. Kjeldsen, Reinhold Kreutz, Stéphane Laurent, Professor Gregory Lip, Richard McManus, Krzysztof Narkiewicz, Frank Ruschitzka, Roland E. Schmieder, Е. V. Shlyakhto, Konstantinos Tsioufis, Victor Aboyans, Iléana Desormais
Discussion(0)
No comments yet. Be the first to comment.